Cyient is grappling with multiple challenges, including disappointing Q3 results, a downward revision in FY25 growth guidance, and the CEO's resignation, all of which have dampened investor sentiment.

Nuvama slashed its FY25 and 26 EPS estimates by 10.8 per cent and 4.5 per cent, respectively, on lower growth and margins. It ...